BioSpace News Archive

BioCapital

Rexahn Pharmaceuticals, Inc. Awarded U.S. Patent for Novel Anti-Cancer Compounds

June 17, 2013
·
1 min read
Drug Development

NPS Pharmaceuticals, Inc. Release: Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients With Hypoparathyroidism

June 17, 2013
·
1 min read
Drug Development

Orexo AB: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv

June 17, 2013
·
1 min read
Pharm Country

Excelsior Medical Corporation Release: SwabCap and SwabFlush Are Focus of Three Studies at APIC Conference

June 17, 2013
·
1 min read
BIOTECanada and BioTalent Canada Announce Partnership to Strengthen Canada’s Bio-Economy

June 17, 2013
·
1 min read
Pharm Country

Advaxis, Inc. Announces Voting Results of 2013 Annual Meeting of Stockholders

June 17, 2013
·
1 min read
Genetown

Covidien plc Announces Publication of Final Results of Pipeline Embolization Device Pivotal Study

June 17, 2013
·
1 min read
Drug Development

Celgene International Sárl Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease

June 17, 2013
·
1 min read
Drug Development

MannKind Corporation Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes

June 17, 2013
·
1 min read
Drug Development

Incyte Corporation Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients With Myelofibrosis

June 17, 2013
·
1 min read